Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FDM21
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,463
Award facts
- Contract value 100% obligated
- $48,463.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $48,463.08 for Stelara 90 mg/ml syringes. The award, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026, enabling the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities.
Stelara is a branded immunosuppressant injection used to treat conditions such as plaque psoriasis, psoriatic arthritis, and Crohn's disease. Through its established IDC vehicle with the DLA, DMS Pharmaceutical Group has demonstrated consistent capability in delivering specialized pharmaceutical products, including biologics and prescription medications, directly to Department of Defense healthcare sites nationwide. The company's positioning as a critical supplier in the federal pharmaceutical supply chain reflects the DLA's reliance on experienced distributors to maintain adequate medical supply inventories across military health facilities.
Quick answers
Who was awarded contract SPE2DB25FDM21?
SPE2DB25FDM21 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FDM21 worth?
The government has obligated $48,463 on SPE2DB25FDM21.
Is contract SPE2DB25FDM21 an order under another contract?
Yes. SPE2DB25FDM21 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM21 competed?
The extent of competition for SPE2DB25FDM21 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award